3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:千円)

 

前連結会計年度

(2025年1月31日)

当連結会計年度

(2026年1月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

2,921,402

15,083,233

前渡金

269,881

198,936

その他

144,296

207,376

流動資産合計

3,335,580

15,489,546

固定資産

 

 

有形固定資産

 

 

建物及び構築物

22,943

27,200

工具、器具及び備品

33,522

71,034

減価償却累計額

24,906

29,119

建設仮勘定

8,761

有形固定資産合計

40,319

69,115

無形固定資産

43,891

43,891

投資その他の資産

 

 

その他

27,547

18,986

投資その他の資産合計

27,547

18,986

固定資産合計

111,759

131,993

資産合計

3,447,339

15,621,539

負債の部

 

 

流動負債

 

 

1年内返済予定の長期借入金

268,000

129,000

未払金

139,077

165,452

未払費用

304,830

212,671

未払法人税等

345

1,210

賞与引当金

9,593

12,523

その他

10,230

13,436

流動負債合計

732,076

534,293

固定負債

 

 

転換社債型新株予約権付社債

1,109,700

長期借入金

129,000

繰延税金負債

823,340

372,879

固定負債合計

952,340

1,482,579

負債合計

1,684,417

2,016,873

純資産の部

 

 

株主資本

 

 

資本金

2,496,192

8,375,431

資本剰余金

6,207,634

12,086,873

利益剰余金

698,901

995,899

自己株式

1,128

1,164

株主資本合計

8,003,796

19,465,240

その他の包括利益累計額

 

 

為替換算調整勘定

6,448,629

6,126,751

その他の包括利益累計額合計

6,448,629

6,126,751

新株予約権

207,754

266,177

純資産合計

1,762,921

13,604,666

負債純資産合計

3,447,339

15,621,539

 

E3138245920サンバイオ株式会社SanBio Company Limited通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-02-012026-01-31FY2026-01-312024-02-012025-01-312025-01-311falsefalsefalse459202025-02-012026-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202025-02-012026-01-31jppfs_cor:ShareholdersEquityMember459202025-02-012026-01-31jppfs_cor:RetainedEarningsMember459202025-02-012026-01-31jppfs_cor:CapitalSurplusMember459202025-02-012026-01-31jppfs_cor:CapitalStockMember459202025-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202025-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202025-01-31jppfs_cor:ShareholdersEquityMember459202025-01-31jppfs_cor:RetainedEarningsMember459202025-01-31jppfs_cor:CapitalSurplusMember459202025-01-31jppfs_cor:CapitalStockMember459202024-02-012025-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202024-02-012025-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202024-02-012025-01-31jppfs_cor:ShareholdersEquityMember459202024-02-012025-01-31jppfs_cor:RetainedEarningsMember459202024-02-012025-01-31jppfs_cor:CapitalSurplusMember459202024-02-012025-01-31jppfs_cor:CapitalStockMember459202024-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202026-03-17459202026-01-31459202025-02-012026-01-31459202025-01-31459202024-02-012025-01-31459202024-01-31459202024-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202024-01-31jppfs_cor:ShareholdersEquityMember459202024-01-31jppfs_cor:RetainedEarningsMember459202024-01-31jppfs_cor:CapitalSurplusMember459202024-01-31jppfs_cor:CapitalStockMember459202026-01-31jppfs_cor:SubscriptionRightsToSharesMember459202025-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-02-012025-01-31jppfs_cor:TreasuryStockMember459202024-01-31jppfs_cor:TreasuryStockMember459202026-01-31jppfs_cor:TreasuryStockMember459202025-02-012026-01-31jppfs_cor:TreasuryStockMember459202025-01-31jppfs_cor:TreasuryStockMember459202025-02-012026-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-02-012025-01-31jppfs_cor:SubscriptionRightsToSharesMember459202026-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202026-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202026-01-31jppfs_cor:ShareholdersEquityMember459202026-01-31jppfs_cor:RetainedEarningsMember459202026-01-31jppfs_cor:CapitalSurplusMember459202026-01-31jppfs_cor:CapitalStockMember459202025-02-012026-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMemberiso4217:JPYxbrli:pure